Morgan Stanley Upgrades Grindr to Overweight, Sees 25% Upside on AI and Telehealth Push
New Edge AI tier and Woodwork telehealth expected to drive strong revenue growth.
Already have an account? Sign in.
New Edge AI tier and Woodwork telehealth expected to drive strong revenue growth.
Accelerating U.S. heart, liver & lung transplants plus strong flight data signal major growth ahead.
Culper Research argues Tarsus is significantly overvalued, disputing the addressable market for its Demodex blepharitis drug XDEMVY.
UnitedHealthcare will begin reimbursing Guardant Health’s Shield colorectal cancer blood test from August 1, driving strong investor reaction and broader commercial access.